WILMETTE, Ill., Feb. 22, 2024 Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced promising.
Monopar Therapeutics (MNPR) Reports Preclinical Data for MNPR-101 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Monopar Announces Promising Preclinical Data For Its MNPR-101 Radiopharma Program Targeting Advanced Cancers menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
David Schonthal
Age: 37| Co-founder | Matter | @davidschonthal I feel like a lot of the energy behind what I do is often equally divided between competitive and collaborative, he says. But all in a positive way.
The idea for stitching together Chicago s health-tech community was hatched on a plane to San Diego. David Schonthal had moved here so he and his wife could be closer to family. Working in health care venture capital, he was frustrated to find the Midwest scene so disjointed that he had to continually return to California for business. The four-hour commute allowed plenty of time for pondering such questions as Why can t we do cool stuff in Chicago?